ABT-450/r–Ombitasvir and Dasabuvir with Ribavirin for Hepatitis C with CirrhosisFred Poordad, Barry Bernstein, Christophe Hézode et al.|New England Journal of Medicine|2014Cited by 877
Tremelimumab in combination with ablation in patients with advanced hepatocellular carcinomaAustin G. Duffy, Tim F. Greten, Mei ElGindi et al.|Journal of Hepatology|2016Cited by 817
The state of hepatitis B and C in Europe: report from the hepatitis B and C summit conference*Angelos Hatzakis, Harry L.A. Janssen, Suzanne Wait et al.|Journal of Viral Hepatitis|2011Cited by 234
Probability of HBsAg loss after nucleo(s)tide analogue withdrawal depends on HBV genotype and viral antigen levelsMilan J. Sonneveld, Benjamin Maasoumy, Shao‐Ming Chiu et al.|Journal of Hepatology|2022Cited by 121
Prediction of Sustained Response After Nucleo(s)tide Analogue Cessation Using HBsAg and HBcrAg Levels: A Multicenter Study (CREATE)Milan J. Sonneveld, Benjamin Maasoumy, Jun Yong Park et al.|Clinical Gastroenterology and Hepatology|2020Cited by 103